# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 4047 results.
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Status: Completed
Last Changed: Mar 08, 2019
First Received: Sep 14, 2017
Disease(s): Hepatitis E, Hepatitis Chronic Viral
Intervention(s): Sofosbuvir
Locations: Hannover Medical School, Clinic for Gastroenterology, Hepatology, and Endocrinology, Hanover, Lower Saxony, Germany
Charité, Campus Virchow-Klinikum, Medical Department, Division of Hepatology and Gastroenterology, Berlin, Germany
University Medical Center Hamburg-Eppendorf, Center for Internal Medicine, I. Medical Clinic and Polyclinic, Hamburg, Germany
Immune Cell Dysfunction in Severe Alcoholic Hepatitis
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Oct 27, 2014
Disease(s): Hepatitis
Locations: Basildon and Thurrock University Hospitals NHS FT, Basildon, Essex, United Kingdom
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
Status: Enrolling by invitation
Last Changed: Mar 09, 2020
First Received: Apr 30, 2018
Disease(s): Hepatitis B
Locations: National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Status: Completed
Last Changed: May 18, 2016
First Received: Apr 15, 2015
Disease(s): Hepatitis E
Intervention(s): Recombinant Hepatitis E Vaccine (Escherichia Coli)
Locations: Kaihua Center for Disease Control and Prevention, Quzhou, Zhejiang, China
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir
Status: Recruiting
Last Changed: May 13, 2020
First Received: Jan 28, 2019
Disease(s): Hepatitis C, Acute Hepatitis C
Intervention(s): Sofosbuvir and Velpatasvir
Locations: Allgemeinmedizinische und internistische Praxis, Berlin-Friedrichshain, Germany
Zentrum für Infektiologie Prenzlauer Berg, Berlin, Germany
Charité Campus Virchow-Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin, Germany
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik I, Bonn, Germany
Universitätsklinikum Essen, Klinik für Gastroenterologie und Hepatologie, Essen, Germany
... and 10 other locations.
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Status: Completed
Last Changed: Aug 26, 2016
First Received: Apr 28, 2016
Disease(s): Hepatitis C
Intervention(s): Alisporivir
Locations: Novartis Investigative Site, La Jolla, California, United States
Novartis Investigative Site, San Diego, California, United States
Novartis Investigative Site, Ventura, California, United States
Novartis Investigative Site, Bradenton, Florida, United States
Novartis Investigative Site, Honolulu, Hawaii, United States
... and 115 other locations.
Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response
Status: Not yet recruiting
Last Changed: Mar 31, 2020
First Received: Mar 30, 2020
Disease(s): Hepatitis B
Intervention(s): Hepatitis B recombinant vaccine
Study of the Clinical Features of Autoimmune Hepatitis
Status: Recruiting
Last Changed: Nov 24, 2020
First Received: Dec 16, 2016
Disease(s): Hepatitis, Autoimmune
Intervention(s): Different biochemical results or pathogenesis.
Locations: Division of Gastroenterology & Hepatology,West China Hospital,Sichuan University, Chengdu, Sichuan, China
DUR-928 in Patients With Alcoholic Hepatitis
Status: Not yet recruiting
Last Changed: Mar 24, 2020
First Received: Apr 17, 2019
Disease(s): Alcoholic Hepatitis
Intervention(s): DUR-928 (Moderate AH), DUR-928 (Severe AH)
Locations: University of Louisville, Louisville, Kentucky, United States
Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis
Status: Recruiting
Last Changed: Aug 31, 2020
First Received: Nov 06, 2018
Disease(s): Alcoholic Hepatitis
Intervention(s): Omega 5 fatty acid supplement, PLACEBO
Locations: Laboratorio de Higado, Pancreas y Motilidad Intestinal. UNIVERSIDAD AUTONOMA DE MEXICO, Mexico City, Cuauhtemoc, Mexico
Hospital General Dr. Manuel Gea Gonzalez, Mexico City, Tlalpan, Mexico